Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
40
NMPA:40
Drug Approvals
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20193246
- Approval Date
- May 11, 2024
NMPA
Parecoxib Sodium for Injection
- Product Name
- 注射用帕瑞昔布钠
- Approval Number
- 国药准字H20193247
- Approval Date
- May 11, 2024
NMPA
Gatifloxacin Dispersible Tablets
- Product Name
- 加替沙星分散片
- Approval Number
- 国药准字H20090213
- Approval Date
- Jan 10, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20163230
- Approval Date
- Jan 10, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20163229
- Approval Date
- Jan 10, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20143188
- Approval Date
- Jan 10, 2024
NMPA
Gabexate Mesylate for Injection
- Product Name
- 注射用甲磺酸加贝酯
- Approval Number
- 国药准字H20093269
- Approval Date
- Aug 23, 2023
NMPA
Pamidronate Disodium for Injection
- Product Name
- 注射用帕米膦酸二钠
- Approval Number
- 国药准字H20093488
- Approval Date
- Aug 23, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found